Trial Profile
Confirmatory study of HFT-290 in patients with chronic pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Mar 2020
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Pain
- Focus Adverse reactions; Registrational; Therapeutic Use
- 18 Mar 2013 New trial record
- 08 Mar 2013 Results published in a Kyowa Hakko Kirin media release.